Objectives To analyse evidence on the effectiveness of intensive NHS treatments for smoking cessation in helping smokers to quit.
Introduction
Cigarette smoking remains the leading cause of preventable death in England today; it is estimated to be responsible for up to 86 500 deaths per year 1 and costs the National Health Service (NHS) between approximately 1.4 and 1.5 billion pounds annually. 2 Since the publication of the White Paper Smoking Kills, 3 the UK government has demonstrated a strong commitment to reducing smoking prevalence 4 through the implementation of an advertising ban, increases in the price of tobacco, a ban on smoking in workplaces and enclosed public places and the creation of a national network of smoking cessation services-known as NHS stop smoking services. 5 NHS stop smoking services represent a unique national initiative to provide support for smokers motivated to quit. 4 -6 The service provision framework employed by the smoking cessation clinics was originally based on the Maudsley model, 7 an evidence-based approach to treating dependent smokers. 8, 9 This approach entails regular meetings (group or one to one) with a trained adviser using structured, withdrawal-oriented behavioural therapy combined with smoking cessation medications such as nicotine replacement therapy (NRT), bupropion or varenicline.
Since the establishment of the services, the Department of Health (DH) has required individual primary care trusts (PCTs) in England to monitor the effectiveness of their local services. This involves regular reporting of the number of people setting a quit date and the number of 4-week quitters. This monitoring data provides an overview of the volume of clients treated by the services (over 2 million people between 2003 and 2007) but has a number of limitations, not least the fact that it relies on self-report rather than carbon monoxide monitoring (CO)-validated outcomes. 10, 11 In addition to routine monitoring, the DH commissioned a national evaluation of the NHS stop smoking services in England between 2001 and 2004; results were published in Addiction in 2005. 12, 13 As part of the process of developing smoking cessation guidance in England, 14 the National Institute for Health and Clinical Excellence (NICE) commissioned a systematic review of existing evidence and this article describes findings from this review. The review aimed to analyse available evidence on the effectiveness of intensive NHS treatments for smoking cessation and to consider the differential impact of treatment on subpopulations. The review therefore reports findings on the effectiveness of cessation interventions in clinical, as opposed to research, settings. As such, and in contrast to other reviews of smoking cessation interventions, it provides evidence of effectiveness in 'real-world' settings.
Methods

Search methods
The review was conducted in May 2006 with an update in November 2007. The literature search was carried out by the Centre for Reviews and Dissemination at the University of York. Articles from 1990 to 2007 written in English were searched in the following bibliographic databases: Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effectiveness, Health Technology Assessment Database, National Research Register (including CRD ongoing reviews database), SIGN Guidelines, National Guideline Clearinghouse, HSTAT, TRIP and Medline.
However, because the services have been in existence for less than 10 years, it was expected that some relevant studies would be found in the grey literature. Grey literature was accessed through three avenues: (i) the National Research Register; (ii) the Smoking Cessation Services Research Network and (iii) tobacco control experts within academia and government.
To be included in the review, studies had to fulfil each of the following criteria: (i) They had to examine smoking cessation interventions provided within the NHS in the UK. Although the review focused on England, studies from other parts of the UK were included. (ii) The interventions had to be moderately intensive or intensive interventions conducted through the NHS; brief interventions (such as brief advice to stop smoking by a health professional) were not included.
The literature search generated 5131 citations. Before acquiring papers for assessment, titles were initially scanned by one reviewer who removed the irrelevant studies. The remaining 292 abstracts were independently scrutinized by two reviewers and those that did not fulfil the inclusion criteria were eliminated. Sixty-nine studies, reports and reviews remained and were acquired for assessment. Upon examination of the full articles, 14 published studies met the inclusion criteria for this review. A further 25 reports were acquired through the grey literature search, and 6 met the inclusion criteria. Thus, in total 20 studies were reviewed.
Methodological quality assessment
Studies were assessed by two reviewers for their methodological rigour and quality based on the critical appraisal checklists provided in the NICE Public Health Guidance Methods Manual. 14 Each study was categorized by study type and graded using a code 'þþ', 'þ' or '-', based on the extent to which the potential sources of bias had been minimized (see Tables 1 and 2 ). Those studies that received discrepant ratings from the two reviewers were given to a third reviewer for final evaluation. Unpublished data was subjected to a quality assessment in the same way as published studies.
Results
Short-and longer term quit rates
The overall effectiveness of NHS stop smoking services in England was assessed as part of the national evaluation of services that reported in 2005. This high-quality study (2þþ) described self-report and CO-validated quit rates at 4 and 52 weeks. At 4 weeks, 53% of clients were recorded as CO-validated quitters, rising to 60.7% when self-report cases were included. 15 At 1 year, 14.6% of clients were CO-validated as abstinent, rising to 17.7% when self-report cases were included. 13 These results are comparable with previous trials of intensive smoking cessation interventions published in the international literature. Other studies included in this review also reported short-and longer term quit rates but these were either recorded as part of a comparison of treatment models (described below) or as part of a study that did not include biochemical validation and was assessed as poor quality.
Intervention type and evidence of effectiveness
Group versus one-to-one interventions Two high-quality (2þþ) observational studies indicate that group treatment for smoking cessation may be more effective than one-to-one treatment. 15, 16 The national evaluation of the services found that although the vast majority of users received one-to-one support, group counselling substantially improved (OR: 1.38) CO-validated quit rates. 15 Another study of group treatment for smoking cessation versus one-to-one treatment in primary care also found that group treatment was more successful. 16 Results indicated that 30% of clients receiving group treatment and 19% of clients receiving one-to-one treatment were CO-validated as continuously abstinent at 4 weeks (OR: 2.27).
Buddy interventions
Some NHS stop smoking services have experimented with 'buddy' interventions, where individual smokers pair up to offer each other mutual support with their quit attempts. Two high-quality (1þþ) randomized controlled trials (RCTs) have explored the impact of 'buddy' conditions on the effectiveness of intensive interventions: one in the context of individual counselling and the other in the context of group counselling. The study exploring 'buddy' interventions in the context of individual counselling 17 found that the odds of patients in the buddy condition remaining abstinent (based on CO validation) after 4 weeks was 2.6 times higher than patients in the solo condition. However, the second RCT found that buddy interventions did not have an additive effect to group smoking cessation interventions. 18 The findings of these studies indicate that while buddy systems may be more than double the 4-week effectiveness of one-to-one interventions, they do not substantially increase the effectiveness of group interventions.
Inpatient interventions
Although there has been recent progress in NHS stop smoking services entering hospital settings 19 the search only identified one published study that explored the effectiveness of inpatient interventions in a UK setting. This mediumquality (1þ) experimental study focused on whether NRT increases the effectiveness of inpatient smoking cessation interventions and included inpatients with smoking-related diseases randomized to receive either NRT plus advice and support or advice and support only. 20 The study found that for both the intervention and control groups the percentage of quitters at 1 year was approximately 14%, which is in line with the long-term abstinence rates reported for the NHS stop smoking services more generally. High-quality systematic reviews of these types of studies, or individual, non-RCTs, case -control studies, cohort studies, CBA studies, ITS and correlation studies with a very low risk of confounding, bias or chance and a high probability that the relationship is causal 2 þ Well conducted non-RCTs, case -control studies, cohort studies, CBA studies, ITS and correlation studies with a low risk of confounding, bias or chance and a moderate probability that the relationship is causal
Non-RCTs, case -control studies, cohort studies, CBA studies, ITS and correlation studies with a high risk-or chance-of confounding bias, and a significant risk that the relationship is not causal 3
Non-analytic studies (for example, case reports, case series)
Expert opinion, formal consensus
Grading the evidence þþ High quality All or most of the quality criteria have been fulfilled
Where they have been fulfilled the conclusions of the study or review are thought very unlikely to alter þ Medium quality Some of the criteria have been fulfilled
Where they have been fulfilled the conclusions of the study or review are thought unlikely to alter 2
Low quality Few or no criteria fulfilled
The conclusions of the study are thought likely or very likely to alter RCTs, randomized controlled trials. (18) when self-reported quitters were included.
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Impact of intensity of the intervention on effectiveness
The national evaluation found that CO-validated 4-week quit rates were enhanced by the number of individual sessions in a complete treatment course. 4 Another high-quality evaluation (2þþ) of the NHS smoking cessation services in Glasgow also found that the more intensive smoking treatment services achieved higher 4-week quit rates (44.4%) than less intensive pharmacy-delivered interventions, which achieved 4-week CO-validated quit rates of approximately 20%. 21 On the other hand, in the context of interventions provided in the primary care settings, a high-quality (1þþ) RCT has found no benefit from adding an extra visit and two additional phone calls to the programme of one-to-one support usually provided by NHS smoking cessation services in primary care. 22 The authors argue that the intervention failed to have a significant effect because the additional support was not delivered in a systematic way across the NHS services participating in the trial. They also suggested that the behavioural support that was provided may have lacked efficacy because many services use primary care providers to provide less intensive support geared largely towards ensuring that medication is used effectively; thus, these community advisors may have less experience in delivering behavioural support. Overall, therefore, there is some evidence that intensive interventions achieve higher success rates than less intensive interventions delivered in primary care settings, but this is an area for further research.
Effectiveness of interventions for particular subpopulations
Younger and older smokers Three high-quality (2þþ) studies, 21, 23, 26 one mediumquality (2þ) study 25 and one low-quality (22) study 24 have found that there is a relationship between quit status at 4 weeks and age, with younger smokers significantly less likely to achieve abstinence through the smoking cessation services than older smokers. A fourth high-quality (2þþ) study found that this effect was also evident at 1 year. 15 Men and women A range of observational studies (3 high-quality [2þþ] studies and 1 low-quality [22] study) have found that women are less likely to successfully achieve short-term abstinence through the NHS stop smoking services than men, although they are more likely to access services. 13, 21, 23, 24 For example, the evaluation of the stop smoking services in Glasgow found that women were less likely to be CO-validated as successful quitters at 4 weeks Patients attended private sessions alone or in pairs with clinic nurse.
Smokers abstinent at the end of the treatment was significantly higher in the buddy condition than the solo condition (27% versus 12%, P ,
0.01).
than men (40.5% versus 53.2%), although they constituted over two-thirds of the clients accessing the services.
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Black and minority ethnic groups Extremely limited information exists on how readily black and minority ethnic groups (BMEG) are accessing the services and how successful they are in completing treatment.
A medium-quality (2þ) study conducted in the Northeast found that CO-validated quit outcome at 4 weeks did not vary with the broad ethnic categories of 'white' and 'nonwhite'; 25 however, as the numbers of people setting quit dates from BMEG was small, this makes interpretation of the data difficult.
Pregnant women
The national evaluation (2þþ) of the NHS stop smoking services found a self-reported quit rate at 4 weeks of 40.5% amongst pregnant women. 13 However, the CO-validated success rate for these pregnant women was 37.2%. A more recent medium-quality (2þ) study of an NHS cessation service targeted at younger, deprived pregnant women in Scotland found medium-term (12-week) CO-validated quit rates of 20.3%, rising to 22.8% when self-report quitters were included, and longer term (52-week) CO-validated quit rates of 12.7%, rising to 16.5% with self-report cases. 26 
Deprived populations
There is a body of evidence from a range of observational studies of varying quality that the NHS stop smoking services have been successful in attracting smokers from deprived areas, although these smokers are significantly less likely to quit successfully than smokers from more affluent areas. Four high-quality (2þþ) studies 4, 23, 27, 28 and a medium-quality (2þ) study 25 found evidence of 'positive discrimination' in the reach of NHS stop smoking services, although services operating in deprived areas achieved lower cessation rates. One medium-quality 29 (2þ) and one lowquality (22) assessment 24 of the stop smoking services also report that manual and routine groups had good access rates but poor quit rates. Two of the high-quality studies also disaggregated their results by sex as well as level of deprivation; 23, 27 neither study found gender differences in quitting success amongst deprived smokers.
Most recently, a medium-quality observational study (2þ) assessed the likely impact of NHS stop smoking services on reducing inequalities in health. 30 This study used routine monitoring data collected from services to compare outcomes between more deprived 'Spearhead' areas in England and less deprived areas. The study found that although cessation rates were lower in more deprived areas, the proportion of smokers reached by services was higher and the net effect was that a higher proportion of smokers in the more disadvantaged areas reported success at 4 weeks (8.8%) than in more affluent areas (7.8%). The authors concluded that NHS smoking cessation services were making a modest contribution to reducing inequalities in health. 30 
Discussion
Main findings of this study
The available evidence suggests that NHS stop smoking services are effective in supporting smokers to quit in the short-and longer term. There is some evidence to suggest that group interventions appear to be more effective than one-to-one interventions within NHS services. While 'buddy' systems may increase the CO-validated 4-week effectiveness of one-to-one interventions, they do not substantially increase the effectiveness of group interventions for smoking cessation. One study also indicates that inpatient interventions for those with smoking-related diseases are just as effective in the long term as the smoking cessation services more generally. The intensity of the intervention also appears to be integral to its effectiveness, although it may act in conjunction with other specific service characteristics.
Theoretically, these findings provide some support for intensive group interventions over other formats. Yet the reality is that this option is not attractive for many smokers, or feasible to deliver, especially in rural regions. Many clients express a clear preference for one-to-one treatment. 31 Moreover, although support delivered by community advisors (e.g. pharmacists) may not achieve the same quit rates as more intensive interventions, these providers are in an excellent position to reach a wide variety of smokers, particularly smokers from deprived areas and those people who are not interested in attending stop smoking groups. 16 There is good evidence that older smokers are more likely to quit successfully than young smokers. Men also appear to be more successful at quitting than women, despite the fact that more women attend the smoking cessation services. These findings support international research that suggests that while women are highly motivated to quit smoking, men tend to be more successful at doing so. 33 There are several factors that seem to explain the lower success rates of women, such as less confidence in relation to quitting, the inter-relationship between gender and deprivation and differences in the meaning and role of tobacco in men and women's lives. 13,32 -36 The evidence on the effectiveness of stop smoking interventions for minority ethnic groups is inconclusive. Although a body of indicative information about the smoking patterns of BMEG indicates that there may be a lack of awareness of the health effects of smoking in BMEG 37,38 as well as a lack of knowledge about the range of available smoking cessation methods and services, 38 -40 there is no available robust evidence on how regularly BMEG access NHS stop smoking services and how effective they are for ethnic minorities.
Pregnant women and more disadvantaged groups face particular challenges in quitting. Pregnant smokers who enrol in smoking cessation programmes may merely suspend their smoking behaviour for the duration of their pregnancy as opposed to quit altogether. 41 They are also more likely to be from routine and manual groups and may experience multiple barriers that make resisting relapse for long-term smoking cessation difficult. 42, 43 Similar difficulties face smokers from areas of deprivation more generally. Smoking is more prevalent among routine and manual groups. In some areas of deprivation, smoking is perceived as the norm, which makes quitting harder. 44 -46 Reported barriers to accessing smoking cessation services are factors such as cost, timing, lack of childcare, lack of appropriate information, perceived ineffectiveness and negative publicity. 47 Another key barrier to quitting is the high level of nicotine dependence among routine and manual groups. Studies have shown that low socio-economic status (SES) smokers are often more highly addicted, have been smoking since a young age, and smoke more cigarettes per week compared with professional workers. 26, 45, 47 However, despite these barriers, there is some encouraging evidence that the NHS are making a modest contribution to reducing inequalities in health by supporting a larger proportion of deprived smokers to quit than their more affluent neighbours. 30 Given the differences between smokers based on factors such as gender, ethnicity, class, age and level of dependency, it is possible that tailored interventions may help to improve cessation rates. For example, two reviews of NHS smoking cessation services for pregnant women provide evidence that the most effective treatment for pregnant smokers entails elements such as systematic training of midwives in how to refer pregnant smokers, offering flexible home visits, and providing intensive multi-session treatment delivered by a small number of dedicated staff. 48, 49 There is now some limited but emerging evidence that modifying the Maudsley model of group treatment to encompass a drop in, rolling element where smokers can continue attending a group at any point in their quit attempt, may be effective in reaching and supporting clients living in deprived areas. 50 -52 This type of adaptation of existing service models may be important if NHS stop smoking services are to continue to be effective as smoking rates become concentrated in more disadvantaged groups.
What is already known on this topic
Studies in the UK and overseas have demonstrated that behavioural support plus access to pharmacotherapy is effective in helping smokers to quit. This combination of support is used by NHS stop smoking services and a number of recent studies have examined their development and outcomes achieved.
What this study adds
This is the first review that brings together all the available published evidence on the efficacy of NHS smoking cessation services. The UK remains the only country in the world to have a comprehensive, free at the point of use cessation service. Results from this systematic review suggest that they provide effective support for smokers who want to quit. However, a number of important research questions remain regarding the efficacy of different forms of intervention offered by the services and, equally importantly, the efficacy of these interventions with different subpopulations of smokers.
Limitations of the study
This review faced two main limitations. The first relates to the research design of the available studies and the second relates to the extent of the evidence. First, conclusions drawn from systematic reviews usually rely on evidence from research that employs a controlled design, allowing explicit comparisons to be made between one type of intervention and another. Only four studies included in this review were RCTs and they examined particular elements of NHS stop smoking services rather than their overall effectiveness. However, to ignore the observational studies included in this review would have resulted in the conclusion that there is almost no reliable evidence regarding the role of these services in helping smokers to quit, which is clearly not the case. Well-designed observational studies yield valuable information about outcomes from 'realworld' services. However, the heavy reliance of this review on observational evidence does mean that a number of caveats have to be placed around the findings.
Secondly, although the vast majority of studies reviewed were of medium-to high quality, another limitation of this review is the lack of available evidence on many of the key issues under consideration. Because the NHS stop smoking services have been in place for under a decade, an adequate evidence base does not yet exist and a number of questions remain to be answered. For example, we have no clear evidence about the impact of service setting, location or, importantly, the quality of behavioural support on cessation outcomes. We also have very little evidence about the most effective way to deliver interventions in hospital settings. It is also clear that a great deal more needs to be learnt about how the characteristics of smokers themselves intersect with each other, and then with service characteristics. The failure of some existing studies to disaggregate their results by sex or ethnicity, and then to fail to apply a gender and diversitybased analysis, limits our knowledge of which interventions work best for particular subpopulations.
